Can You Have Knee Surgery If You Have Afib?

People with atrial fibrillation can and do have knee surgery, including total knee replacement, but the procedure demands significantly more planning and carries measurably higher risks than it does for someone with a normal heart rhythm. The central challenge is not whether the surgery itself is feasible but how to manage the blood-thinning medications that most afib patients take daily. Pausing anticoagulation raises clot risk; continuing it raises bleeding risk. That tension shapes almost every decision your surgical and cardiology teams will make around the operation.

What the Research Says About Outcomes

A retrospective study comparing total knee arthroplasty outcomes in patients with and without afib found that afib patients had significantly higher odds of intraoperative bleeding, periprosthetic joint infection, postoperative stroke, and postoperative cardiovascular events. At about two years out, afib patients also scored worse on physical and mental quality-of-life measures. On the positive side, the study found no increased incidence of deep vein thrombosis or pulmonary embolism in the afib group compared to patients without the condition.¹

A separate analysis of hip and knee arthroplasty patients with pre-existing afib found they were more likely to develop acute kidney injury after total knee replacement and had higher rates of 30-day readmission compared to patients without afib.² None of this means the surgery is off the table. It means you and your medical team should go in with clear expectations: recovery may be bumpier, and there is a higher chance of complications that extend your hospital stay or require additional treatment.

The Anticoagulation Problem

Most people with afib take a blood thinner to prevent stroke. The two broad categories are warfarin (an older vitamin K antagonist) and direct oral anticoagulants, sometimes called DOACs, which include drugs like apixaban and rivarelbant. Knee replacement is classified as a high bleeding risk procedure. A systematic review of perioperative DOAC management specifically listed bilateral knee replacement and any major surgery lasting over 45 minutes among procedures with increased bleeding risk.³ That classification matters because it determines how far in advance you stop the medication and whether you need temporary injectable blood thinners to cover the gap.

DOACs have a shorter half-life than warfarin, which means they leave your system faster. Surgeons and anesthesiologists typically ask patients to stop them two to four days before a high-risk procedure, depending on kidney function and the specific drug. Warfarin, by contrast, takes longer to wear off and requires monitoring through blood tests (INR levels) to confirm it has cleared enough for safe surgery. The decision about when to stop, whether to bridge, and when to restart is not one-size-fits-all, and it will usually involve your cardiologist and surgeon coordinating directly.

Bridging Therapy and Its Risks

Bridging therapy means using a short-acting injectable blood thinner, usually low-molecular-weight heparin or unfractionated heparin, during the window when your oral anticoagulant has been stopped before surgery. The idea is to keep you protected from stroke while still allowing the surgical team a window of reduced bleeding risk. It sounds logical, but the evidence on bridging for joint replacement is complicated and, honestly, a bit unsettling.

One study of patients on oral anticoagulants who underwent total hip or knee replacement found that bridged patients had more blood loss and higher complication rates than a control group. Most of those complications were bleeding-related. Among total hip patients bridged with unfractionated heparin, half required reoperation, primarily for blood-collection complications. Two patients bridged with low-molecular-weight heparin died from bleeding-related causes. Meanwhile, there were no thromboembolic events in the bridged group, meaning the bridging did seem to prevent clots, but at a steep cost in bleeding complications. Hospital stays were also significantly longer for bridged patients.⁴

Other research has produced a more mixed picture. A study of 649 fast-track total hip and knee arthroplasties comparing bridging to simply pausing the vitamin K antagonist found no statistically significant differences in blood clot events, blood vessel blockages, or major bleeding between the two groups. That said, the researchers noted that paused patients trended toward more clot events and bridged patients trended toward more bleeding, and they called for larger studies before drawing firm conclusions.⁵

Complicating matters further, an analysis of real-world insurance data found that bridged therapy was actually associated with significantly lower rates of blood clots and minor bleeding compared to nonbridged therapy after hip or knee replacement, though major bleeding rates were similar between the groups.⁶ The takeaway from all of this is that bridging is not clearly better or worse than simply pausing anticoagulation. The right approach depends on your individual stroke risk, your particular anticoagulant, and your surgical team’s experience. If your cardiologist says bridging is necessary because your stroke risk is high, that is a case where the bleeding risk may be worth accepting.

Restarting Blood Thinners After Surgery

Getting your anticoagulation back on track after the operation is its own balancing act. Restart too early and you risk a surgical bleed. Restart too late and you risk a stroke or blood clot. For patients on warfarin, one set of recommendations suggests restarting at a loading dose, typically double the patient’s usual maintenance dose for the first two doses, beginning on the evening of surgery. Daily INR monitoring starts after the second dose, ideally using point-of-care testing devices, with subsequent dosing guided by an anticoagulation service.⁷

For DOACs, the restart is generally simpler because these drugs reach full effect within hours rather than days. Most protocols call for resuming them one to three days after surgery, depending on how quickly hemostasis (stable wound clotting) is achieved. Your surgical team will assess your wound drainage and any signs of bleeding before giving the green light. Either way, the restart strategy should be discussed and agreed upon before the surgery happens, not improvised afterward.

Anesthesia Considerations

Knee replacement can be performed under general anesthesia, spinal anesthesia, or a combination that includes regional nerve blocks. For afib patients on anticoagulants, the type of anesthesia matters more than you might expect. Spinal and epidural techniques involve placing a needle near the spinal cord, and any residual anticoagulation increases the risk of spinal hematoma, a rare but serious complication where blood collects around the spinal cord and can cause permanent nerve damage.

American Society of Regional Anesthesia guidelines note that while spinal hematoma is rare in the general population, its frequency may be as high as roughly 1 in 3,000 in some higher-risk patient groups. Risk factors include advanced age, spinal abnormalities, underlying coagulopathy, difficulty placing the needle, and having a neuraxial catheter in place during sustained anticoagulation.⁸ The practical implication is that your anesthesiologist needs to know exactly when your last dose of blood thinner was, down to the hour, and will plan the anesthesia approach around that timeline. In some cases, general anesthesia may be chosen specifically to avoid spinal needle placement in a patient whose anticoagulation status is uncertain.

Optimizing Your Heart Before Surgery

Going into surgery with your afib as well controlled as possible makes a measurable difference. The same study that tracked knee replacement outcomes in afib patients identified several risk factors for the most severe complications, including stroke and cardiovascular events. Among the modifiable ones, smoking and diabetes were common risk factors for periprosthetic infection, stroke, and cardiovascular events. A resting heart rate above 70 beats per minute and not being on a beta blocker were also linked to higher odds of stroke and cardiovascular events after surgery.¹

What this means practically: if you smoke, quitting before surgery reduces your complication risk. If your resting heart rate tends to run high, talk to your cardiologist about rate control, potentially with a beta blocker if you are not already on one. If you have diabetes, getting your blood sugar well managed before the procedure matters. These are not just general health advice platitudes; they are specific, data-supported risk factors for the exact complications that threaten afib patients undergoing knee replacement. A preoperative cardiology clearance visit should address all of them, and you should consider it an essential step, not a formality.

The type of afib also matters. Persistent afib, where the irregular rhythm is present most or all of the time, was identified as a risk factor for serious complications, whereas paroxysmal afib (episodes that come and go) may carry somewhat lower surgical risk. Your cardiologist can help characterize which type you have and whether any rhythm-control interventions, like cardioversion or catheter ablation, would be worth pursuing before elective knee surgery.

Expect a Longer Hospital Stay

One of the less-discussed realities for afib patients is that everything around the surgery takes longer. A study examining hospital burden found that patients with afib undergoing total joint arthroplasty had a preoperative length of stay averaging about 1.7 days compared to 0.2 days for non-afib patients, a postoperative stay of about 4.6 days versus 3.2 days, and a total stay of roughly 6.3 days compared to 3.4 days.⁹ That nearly doubled total stay reflects the extra time needed to manage anticoagulation, monitor for cardiac events, and ensure the wound is stable before discharge.

The financial and logistical implications are real. You may need to arrange for more time off work and more help at home than a typical knee replacement patient. If you are planning the surgery electively, factor this into your timeline. The preoperative admission time also means you may be admitted the day before surgery rather than the morning of, so the team can check labs, confirm anticoagulation status, and make any last adjustments to medications.

When to Consider Nonsurgical Alternatives

Given the added risks, it is worth asking whether you truly need surgery or whether you can manage your knee problem another way, at least for now. For knee osteoarthritis, which is the most common reason people end up considering knee replacement, the menu of nonsurgical options is broader than many people realize. It includes physical therapy, biomechanical interventions like braces and orthotics, intra-articular injections of corticosteroids or hyaluronic acid, nerve blocks targeting the geniculate nerves around the knee, radiofrequency ablation, and regenerative approaches like platelet-rich plasma injections.¹⁰

For someone with afib, these options carry the added benefit of not requiring you to stop your anticoagulation. Most injections can be done safely while you remain on blood thinners, and physical therapy obviously requires no medication changes at all. A case report described a patient who, after completing cardiac rehabilitation followed by a structured exercise and education program for knee osteoarthritis, reduced average knee pain by about 76% and improved joint-related quality of life substantially. At the two-year follow-up, that patient had still not needed a knee replacement.¹¹ One case report is not a guarantee, but it illustrates that aggressive nonsurgical management can meaningfully delay or even eliminate the need for surgery in some patients, and that benefit is amplified when surgery itself carries extra cardiac risk.

None of this means you should avoid surgery if your knee pain is severe, you have exhausted conservative options, and your medical team believes the procedure is safe. It means the bar for surgery should be a bit higher when you carry afib risk, and you should make sure less invasive options have genuinely been tried and failed before committing to an operation.

What About Arthroscopy and Other Less Invasive Knee Procedures

Not all knee surgery is a full replacement. Arthroscopic procedures, meniscus repairs, ligament reconstructions, and partial knee replacements all exist on a spectrum of invasiveness. The anticoagulation considerations still apply, but the bleeding risk generally scales with the size and duration of the procedure. A short arthroscopy lasting under 45 minutes carries a different risk profile than a two-hour total knee replacement. Your surgeon and cardiologist may agree that a shorter, less invasive procedure requires only a brief pause in anticoagulation, or in some cases, no pause at all with DOACs.

That said, the evidence base on afib and knee surgery is heavily weighted toward total knee arthroplasty because that is the most studied procedure. If you are having a less invasive operation, your team will likely extrapolate from general perioperative anticoagulation guidelines rather than from joint-specific research. The principles remain the same: assess individual clot risk, decide on a medication plan, and monitor closely around the procedure.

Wearable Monitoring After Surgery

One emerging trend that could benefit afib patients after knee surgery is remote monitoring using smartwatch technology. A systematic review of smartwatch interventions in healthcare found positive outcomes across a range of conditions, including improved atrial fibrillation diagnosis, reduced unplanned hospital readmissions, and better medication adherence. The review also noted benefits for patients after knee arthroplasty, including functional assessment tracking and reduced healthcare resource use.¹²

For an afib patient recovering from knee surgery, a wearable device could serve a dual purpose: tracking heart rhythm for any new episodes of irregular heartbeat (which surgery and the stress of recovery can trigger) while also monitoring activity levels and rehabilitation progress. This is still a developing area, and your doctor is unlikely to prescribe a smartwatch as part of your postoperative plan just yet. But if you already wear one, sharing the data with your care team during recovery could help catch problems early, particularly rhythm changes that might affect when or how your anticoagulation is managed during the critical first few weeks after surgery.

Why Some Clinical Trials Exclude Afib Patients

If you start reading the research yourself, you may notice something frustrating: many of the largest clinical trials on knee replacement outcomes specifically excluded patients who were already on warfarin for afib. For example, a major randomized trial comparing low-intensity to standard-intensity warfarin for blood clot prevention after hip or knee replacement excluded patients who already had an indication for warfarin, including atrial fibrillation.¹³ This is a common design choice in surgical trials because afib patients on anticoagulants introduce a confounding variable: they are already receiving a drug that prevents clots, which makes it hard to study how a different dose or regimen works in a clean comparison.

The practical consequence is that much of the highest-quality evidence on blood clot prevention after knee surgery does not directly apply to you. Your surgical team is, in a sense, working with less certainty than they would have for a patient without afib. This is not a reason to panic; experienced surgeons and cardiologists manage afib patients through knee surgery routinely. But it is a reason to choose a surgical team that has specific experience with anticoagulated patients and to make sure your cardiologist is actively involved in the perioperative planning, not just signing off on a clearance form.